When do differences in dissolution profiles predict clinical problems?
Ngo
S N T
SN
School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Adelaide, SA, Australia. suong.ngo@unisa.edu.au
D001682:Biological Availability; D002986:Clinical Trials as Topic; D016568:Drugs, Generic / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D017408:Guidelines as Topic; D006801:Humans; D013810:Therapeutic Equivalency; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence / Q000592:standards
D016568:Drugs, Generic